Zanolimumab (HuMax-CD4®), a Fully Human Monoclonal Antibody in Clinical Development for Cutaneous T-Cell Lymphoma. Hematol Meeting Rep 2009, 2 (5). https://doi.org/10.4081/hmr.v2i5.736.